Chief Executive Officer
Dan Croteau has over 30 years of leadership experience with the last 20 years in executive leadership roles in the Medical Device Industry. Dan was most recently President and CEO of Vention Medical, a leading medical device contract manufacturer and product development company. During Dan’s tenure at Vention Medical, sales more than tripled through a combination of acquisitions and organic growth. Prior to Vention Medical, Dan was President of FlexMedical, the medical device and equipment division of Flextronics, responsible for more than $1 Billion annually in sales with manufacturing plants and development centers in Mexico, North America, Europe and Asia. Dan also held roles at Accellent (now part of Integer) as Executive Vice President and General Manager of the Orthopedic Division and in a previous role was Senior Vice President of Corporate Development. Earlier in his career Dan spent several years with GE and the management consulting firm Booz & Company. Dan has an MBA from Harvard Business School and a BS in Mechanical Engineering from the University of Vermont. Dan also serves as a director for UFP Technologies, a publicly traded company that specializes in packaging and materials and Inventus Power, a privately held company that develops and manufactures rechargeable battery/power systems.
Commercial & Strategy
Matt Bastardi has over 20 years of leadership experience in the medical device & diagnostics industry, having managed teams in corporate development, strategic planning, marketing, finance, and operations. Prior to Surgical Specialties, Matt was Senior Vice President, Corporate Development & Strategy for Accriva Diagnostics. Matt helped lead the transformation of Accriva Diagnostics resulting in the sale of the Company to Werfen. Earlier in his career, Matt was Vice President, Portfolio Management, Strategic Marketing & Business Development for Covidien. Matt also held roles in the OEM / contract manufacturing industry serving the medical device industry with FlexMedical and Accellent. He started his career in M&A investment banking for Alex. Brown & Sons. Matt earned an MBA from the Kellogg School of Management at Northwestern University, and a B.S. from Georgetown University.
Operations, Quality, Supply Chain and R&D
Victor has over 20 years of experience in the healthcare, medical device, and medical instrument industries. Prior to joining Surgical Specialties Corporation, Victor was Vice President, Global Operations at Teleflex Medical, the medical device and instrument manufacturing division of Teleflex Corporation. During his career at Teleflex, Mr. Diaz led a staff of 4,200 and was responsible for the global manufacturing, procurement, distribution, and complete supply chain with 25 plants and 23 distribution centers in Europe, Asia, Latin America, and the United States. Previously, Victor served as Vice President of Manufacturing at both Kendall Healthcare, a subsidiary of Tyco Healthcare, and Tyco Healthcare Respiratory. Victor received a BA in Chemistry from the Universidad Autonoma de Baja, California.
Prior to Surgical Specialties, Maura was Director, Human Resources at Pancon Corporation, a global designer and manufacturer of components for the automotive, industrial and appliance industries. Previously, Maura managed Rickney Associates, where she executed retained searches and provided human resources consulting services to medical device and healthcare firms in transition or growth stages. Earlier in Maura’s career she held the role of Vice President, Human Resources at Putnam Investments where she managed the internal Executive Search function and supported the wholesale broker/dealer business unit. Maura was also Director, Human Resources at Fidelity Investments, and an AVP at The Boston Company. Maura holds a Bachelor of Science in Business administration from Rollins College.
James Xu Shubi
Prior to joining Surgical Specialties in 2017 to run our China business, James was the Managing Director of Devicor Medical China. In this role, James was part of the management team that successfully spun off Johnson & Johnson’s breast care business to form Devicor. James helped more than double revenue from 2012 to 2015, leading to the acquisition of Devicor by Danaher. Prior to Devicor, James worked for Johnson & Johnson Medical China for 15 years, a cross numerous specialties including cardiovascular, orthopedics and women’s health. During his time at J&J, James was involved in businesses at various stages from start-up through sustainable growth periods. James graduated from Second Military Medical University in Shanghai, and also holds an MBA from Rutgers University School of Business.
In addition to supporting Surgical Specialties acquisition activities, Joe is a Managing Director for VIVO Capital LLC, the Health Care Investment Firm that led the syndicate group that purchased Surgical Specialties in 2017. Joe has nearly 20 years of experience in life sciences transactions and investments as a private company CEO, investment banker and private investor. Prior to joining Vivo Capital, Joe was the U.S. CEO of a China-focused global medical device company, where he orchestrated five acquisitions and obtained FDA and CE mark approvals for the company’s products. Earlier in his career, Joe was an investment banker involved in over 50 transactions totaling over $1 billion for biopharmaceutical and medical device companies while working for Cowen & Co. and Banc of America Securities. Joe studied at the Beijing Language Institute and graduated with a B.A. from Duke University and an MBA from the University of California at Berkeley.
Ophthalmology and International Sales
Prior to joining Surgical Specialties in 2019, Yong was VP and General Manager of Physiology, Cell and Molecular Instruments at Harvard Biosciences. Previously, he served as Vice President of Global Marketing and Americas Sales at Beaver-Visitec International, a company combining the ophthalmic business units from Becton Dickinson (BD) and Medtronic. Earlier in his career, Yong served in progressive positions at BD, including Director of Global Marketing & U.S. Sales and at Eli Lilly & Company where he was the Marketing Manager, Global Life Sciences Market & Greater China Region. Yong holds an M.B.A. from the MIT Sloan School of Management, a master of science degree in environmental science & engineering from Northeastern University and a bachelor of science degree in biochemistry from Peking University
Dan has experience with both public and private health sciences, medical device and diagnostic companies. Most recently, Dan spent six years as Chief Financial Officer at IQuum, a point of care molecular diagnostics company. Previously, Dan was Chief Financial Officer at Abiomed, a publicly held medical device company serving the cardiology and heart surgery markets. Prior to Abiomed, Dan spent eight years at PerkinElmer, a global S&P 500 company, in a variety of progressive corporate and operational financial management roles including Corporate Director of Accounting and Finance, Director of Finance for the company’s Life and Analytical Sciences $1B business unit, and Corporate Vice President of Investor Relations and Corporate Communications. Earlier in his career, Dan held senior financial management positions at various publicly held manufacturing and financial services firms. Dan is a Certified Public Accountant and has both a Master of Science Degree in Finance and a Bachelor of Science Degree in Accountancy from Bentley University.